Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-496P is annotated as a pseudogene corresponding to the U6 small nuclear RNA family in humans. Pseudogenes are non-functional sequences that arise from once-functional genes that have accumulated mutations or disruptions, such as loss of promoters or coding potential, preventing their normal function. Most pseudogenes, including RNU6-496P, do not have a known protein product or biological activity. Some pseudogenes may be transcribed and can, in rare cases, regulate other genes through RNA-mediated mechanisms (such as acting as competitive endogenous RNAs), but there are no reports of regulatory activity or disease association for RNU6-496P specifically. RNU6-496P is not considered a therapeutic target, receptor, enzyme, or actionable biomolecule. RNU6-496P, or RNA, U6 small nuclear 496, pseudogene, is a non-functional, non-coding RNA pseudogene in humans, part of the family of small nuclear U6 RNA pseudogenes. It is not a therapeutic target and has no reported biological function, interacting substances, or disease associations.
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 496, pseudogene (RNU6-496P).